Tuesday - November 18, 2025

Category Archives: Science

Food Allergy Pipeline Insights Report 2025: Clinical Trial Progress, Breakthrough Drugs, and Companies Shaping the Future of Treatment | DelveInsight

DelveInsight’s “Food Allergy Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Food Allergy pipeline landscape. It covers the Food Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Myocardial Infarction Pipeline Drugs Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s, “Myocardial Infarction Pipeline Insight 2025” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Myocardial Infarction pipeline landscape. It covers the Myocardial Infarction pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Epilepsy Pipeline Drugs Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s “Epilepsy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epilepsy pipeline … Continue reading →

Major Depressive Disorder Pipeline Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

RheeGen and Winback Announce Strategic Partnership to Advance Topical Regenerative & TECAR-Based Recovery Technologies

Dr. Tommy Rhee RheeGen®, a pioneering leader in cell-free topical regenerative therapy, announced today a strategic partnership with Winback, a global innovator in TECAR energy and electrotherapy technologies. Tampa, FL – Nov 10, 2025 – RheeGen®, a pioneering leader in cell-free … Continue reading →

Chronic Traumatic Encephalopathy Pipeline Drugs Report 2025: Companies Accelerate Drug Development Through Advanced Clinical Trials Targeting Effective Treatment Solutions | DelveInsight

DelveInsight’s “Chronic Traumatic Encephalopathy Pipeline Insight 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Chronic Traumatic Encephalopathy pipeline landscape. It covers the Chronic Traumatic Encephalopathy Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Heart Failure Pipeline Insights Report 2025: Novel Treatment Approaches and Clinical Trial Insights from Top Pharma Companies | DelveInsight

DelveInsight’s, “Heart Failure Pipeline Insight 2025” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Heart Failure pipeline landscape. It covers the Heart Failure pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Hot Flashes Pipeline Drugs Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s “Hot Flashes Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Hot Flashes pipeline landscape. It covers the Hot Flashes pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Cholestatic Pruritus Pipeline Drugs Insights Report 2025: Key Companies Lead Breakthrough Clinical Trials to Develop Innovative Treatment Drugs | DelveInsight

DelveInsight’s, “Cholestatic Pruritus Pipeline Insights 2025” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Cholestatic Pruritus pipeline landscape. It covers the Cholestatic Pruritus pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →